Published • loading... • Updated
BioSkryb Genomics Names William E. Evans, Pharm.D. as Chief Executive Officer
Summary by Business Wire
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Business WireReposted by 
HealthTech HotSpot
HealthTech HotSpotBioSkryb Genomics Names William E. Evans, Pharm.D. as Chief Executive Officer
DURHAM, N.C.--(BUSINESS WIRE)--BioSkryb Genomics appointed veteran pharmacogenomics leader and former St. Jude CEO Dr. William Evans to guide BioSkryb’s next phase of growth
·Crystal River, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
